5d 1m 3m 1y 5y 10y
There are no Transcripts on OGEN.
Business Wire (Jan 14, 2014)
Business Wire (Jan 13, 2014)
Business Wire (Nov 20, 2013)
Business Wire (Nov 15, 2013)
Business Wire (Nov 14, 2013)
Business Wire (Oct 31, 2013)
OGEN vs. ETF Alternatives
Oragenics Inc is a biopharmaceutical company which focuses on the discovery, development and commercialization of a variety of technologies associated with oral health, broad spectrum antibiotics and other general health benefits.
Monday, Feb 2412:48 PM|Monday, Feb 2412:48 PM| 1 Comment
Tuesday, Jan 2812:45 PM|Tuesday, Jan 2812:45 PM| Comment!
Friday, Jan 1712:48 PM
Monday, Jan 1312:46 PM
Monday, Nov 182013, 12:45 PM|Monday, Nov 182013, 12:45 PM| 1 Comment
Tuesday, Oct 12013, 10:08 AM
Tuesday, Oct 12013, 10:08 AM| Comment!
- Oragenics (OGEN +3.7%) and Intrexon (XON +0.5%) establish an Exclusive Channel Collaboration for the development and commercialization of "genetically modified probiotics for the treatment of diseases of the oral cavity, throat, sinus and esophagus."
- The companies intends to initially focus on a treatment for oral lesions associated with Behcet's. (PR)
- Previous: XON, OGEN announce results from lantibiotics testing
Monday, Aug 262013, 10:37 AM
Monday, Aug 262013, 10:37 AM| Comment!
- Oragenics (OGEN +1.3%) and recent IPO Intrexon (XON -2%) say that collaborative experiments demonstrate a genetically-modified host can be engineered to produce improved titers of OGEN's lead compound MU1140, progressing towards the commercial production of lantibiotics, a novel-class of broad-spectrum antibiotics.
- The collaboration also uncovered two new methods of purifying its lead compound resulting in higher purity and yields of MU1140.
- OGEN and XON entered into an Exclusive Channel Collaboration agreement to develop and commercialize lantibiotics for the treatment of infectious diseases in June 2012.
Tuesday, Jun 252013, 12:45 PM
Wednesday, Apr 172013, 12:59 PMMidday top 10 gainers: ACUR +53%. ECTY +16%. PCYG +16%. ALKS +15%. OCZ +15%. OGEN +14%. RECV +12%. CASM +11%. ATLS +11%. CHLN +11%.
Midday top 10 losers: EOPN -26%. CNIT -26%. INWK -25%. MHR -21%. CXW -18%. CRMB -16%. CRUS -16%. EPAX -14%. BMI -14%. EMXX -14%. |Wednesday, Apr 172013, 12:59 PM| Comment!